Palvella Therapeutics, Inc.
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
2
Funding Rounds
$55.0m
Money raised
Overview
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Palvella Therapeutics, Inc. has raised a total of $55m in funding over 2 rounds.
Key Insights:
- Palvella Therapeutics, Inc. Series C round, May 2020: $45m
- Palvella Therapeutics, Inc. , December 2018: $10m
Palvella Therapeutics, Inc. Series C round, May 2020
$45m
Palvella Therapeutics, Inc. , December 2018
$10m
Industries
Palvella Therapeutics, Inc. is active in the following industries: